| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |